Jamnikar Uros, Nikolic Petra, Belic Ales, Blas Marjanca, Gaser Dominik, Francky Andrej, Laux Holger, Blejec Andrej, Baebler Spela, Gruden Kristina
Sandoz Biopharmaceuticals, Kolodvorska 27, SI-1234, Menges, Slovenia.
Jozef Stefan Institute, Jamova cesta 39, SI-1000, Ljubljana, Slovenia.
BMC Biotechnol. 2015 Oct 23;15:98. doi: 10.1186/s12896-015-0218-9.
Chinese hamster ovary (CHO) cells have become the host of choice for the production of recombinant proteins, due to their capacity for correct protein folding, assembly, and posttranslational modifications. The most widely used system for recombinant proteins is the gene amplification procedure that uses the CHO-Dhfr expression system. However, CHO cells are known to have a very unstable karyotype. This is due to chromosome rearrangements that can arise from translocations and homologous recombination, especially when cells with the CHO-Dhfr expression system are treated with methotrexate hydrate. The present method used in the industry for testing clones for their long-term stability of recombinant protein production is empirical, and it involves their cultivation over extended periods of time prior to the selection of the most suitable clone for further bioprocess development. The aim of the present study was the identification of marker genes that can predict stable expression of recombinant genes in particular clones early in the development stage.
The transcriptome profiles of CHO clones with stable and unstable recombinant protein production were investigated over 10-weeks of cultivation, using a DNA microarray. We identified 14 genes that were differentially expressed between the stable and unstable clones already at 2 weeks from the beginning of the cultivation. Their expression was validated by reverse-transcription quantitative real-time PCR (RT-qPCR). Furthermore, the k-nearest neighbour algorithm approach shows that the combination of the gene expression patterns of only five of these 14 genes is sufficient to predict stable recombinant protein production in clones in the early phases of cell-line development.
The exact molecular mechanisms that cause unstable recombinant protein production are not fully understood. However, the expression profiles of some genes in clones with stable and unstable recombinant protein production allow prediction of such instability early in the cell-line development stage. We have thus developed a proof-of-concept for a novel approach to eliminate unstable clones in the CHO-Dhfr expression system, which saves time and labour-intensive work in cell-line development.
中国仓鼠卵巢(CHO)细胞已成为生产重组蛋白的首选宿主,因为它们具有正确进行蛋白折叠、组装和翻译后修饰的能力。用于重组蛋白生产的最广泛使用的系统是使用CHO-Dhfr表达系统的基因扩增程序。然而,已知CHO细胞具有非常不稳定的核型。这是由于易位和同源重组可能导致染色体重排,特别是当用甲氨蝶呤处理具有CHO-Dhfr表达系统的细胞时。目前工业上用于测试克隆重组蛋白生产长期稳定性的方法是经验性的,并且在选择最适合进一步生物工艺开发的克隆之前,需要对其进行长时间培养。本研究的目的是鉴定能够在开发阶段早期预测特定克隆中重组基因稳定表达的标记基因。
使用DNA微阵列在10周的培养过程中研究了具有稳定和不稳定重组蛋白生产的CHO克隆的转录组谱。我们鉴定出14个基因,从培养开始2周起,它们在稳定和不稳定克隆之间差异表达。通过逆转录定量实时PCR(RT-qPCR)验证了它们的表达。此外,k近邻算法方法表明,这14个基因中仅5个基因的表达模式组合就足以在细胞系开发的早期阶段预测克隆中重组蛋白的稳定生产。
导致重组蛋白生产不稳定的确切分子机制尚未完全了解。然而,具有稳定和不稳定重组蛋白生产的克隆中一些基因的表达谱允许在细胞系开发阶段早期预测这种不稳定性。因此,我们开发了一种概念验证的新方法,用于在CHO-Dhfr表达系统中消除不稳定克隆,这节省了细胞系开发中的时间和劳动密集型工作。